Login to Your Account

Clinic Roundup

Wednesday, June 15, 2011
Tengion Inc., of East Norriton, Pa., said it is working to collect additional clinical data while modifying the surgical approach for future implants for the Phase I trial with its Neo-Urinary Conduit candidate in patients with bladder cancer who have had cystectomies. The firm expects to submit those data and changes to the FDA in the third quarter, prior to enrolling additional patients in the trial.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription